ACS eliminates 1,000 positions due to fundraising drop

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The American Cancer Society is reducing its overall budget by approximately 30%, with cuts to non-personnel and personnel expenses as a result of a decrease in fundraising revenue.

ACS eliminated 1,000 positions across the U.S.

“We are also making a fundamental shift in how we engage and serve communities. Within a very short period of time, we had to reconfigure our entire portfolio to honor donor dollars and continue to advance our mission amid these very difficult times,” ACS officials said in a statement. “We will continue to engage with people where they live their lives, with a greater emphasis on the digital world in which we live.”

Table of Contents

YOU MAY BE INTERESTED IN

At the Sept. 4 meeting of the National Cancer Advisory Board, NCI Principal Deputy Director Douglas R. Lowy provided an overview of how NCI is weathering the maelstrom of executive orders, policy changes, and funding uncertainties that has come down on federal agencies and research institutes since Donald Trump’s inauguration in January. 
A Senate hearing that the administration hoped would be a routine check-in on the president’s 2026 MAHA-driven healthcare agenda erupted into a political firestorm as senators jumped at their first opportunity to confront HHS Secretary Robert F. Kennedy Jr. over the chaos engulfing the Centers for Disease Control and Prevention.
In December 1971, President Richard Nixon signed the National Cancer Act and declared a “War on Cancer.” In the past 54 years, the U.S. has invested $180 billion nominally, or approximately $322 billion when adjusted for inflation, in cancer research. This investment has paid dividends with more than 100 anticancer drugs brought to market in half a century—virtually all traceable to National Cancer Institute funding. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login